Introduction: The HDP-Gestosis score is a novel clinical risk evaluation method aimed at estimating the likelihood of pre-eclampsia in pregnant women. Women who obtain a score of three or above are considered “at risk,” allowing for early recognition and timely intervention to prevent complications.
Objective To determine the diagnostic efficiency of the HDP-Gestosis score in predicting pre-eclampsia by analyzing its sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy.
Methods: This prospective study was carried out between June 2022 and June 2024, including 210 antenatal women recruited from the Department of Obstetrics and Gynecology. All participants were followed for the onset of pre-eclampsia beyond 20 weeks of gestation. The Gestosis score was assigned individually, and women scoring ?3 were classified as high risk. Statistical tests were applied to assess predictive validity.
Results: The mean age of the study population was 27.36±4.60 years. The HDP-Gestosis score showed a sensitivity of 76.3%, specificity of 77.2%, PPV of 81.1%, NPV of 71.7%, and an overall diagnostic accuracy of 76.7% for forecasting pre-eclampsia.
Conclusion: The HDP-Gestosis score serves as a practical, cost-effective, and clinically valuable tool for early identification of women at high risk of developing pre-eclampsia, particularly in resource-constrained settings.
International Journal of Clinical Obstetrics and Gynaecology
Indexed in Index Copernicus
Research Journals